When doctors suspect an invasive mold infection, treatment usually begins quickly—sometimes even before every test result returns. Here’s a plain-language overview of what therapy may involve.
Common antifungal categories (high level)
- Azoles (triazoles): Often used orally or IV. Teams monitor for drug–drug interactions and may check blood levels (therapeutic drug monitoring) for certain agents.
- Amphotericin B formulations: Given IV in the hospital; teams track kidney function and electrolytes closely.
- Echinocandins: Typically IV; commonly used early or in combination depending on the situation.
Your clinicians choose medicines based on the suspected fungus, site of infection, severity, other illnesses, and how you respond.
How therapy may unfold
- Early IV therapy, then possible “step-down” to oral medicine once you’re stable.
- Length of treatment varies—sometimes weeks to months, guided by imaging, lab trends, and clinical improvement.
- Combination therapy or surgery may be considered in certain infections (for example, debridement in some sinus or skin disease).
Monitoring you might hear about
- Liver tests (LFTs) and kidney function (creatinine, electrolytes).
- Drug–drug interaction checks (particularly with azoles).
- ECG/QTc monitoring when indicated.
- Therapeutic drug monitoring (TDM) for select medicines.
- Follow-up imaging (e.g., chest CT) and repeated labs to gauge response.
Tips for patients & caregivers
- Keep an updated medication list (include over-the-counter and supplements).
- Report new symptoms promptly—fever, shortness of breath, chest pain, vision changes, severe headaches, rashes, or swelling.
- Ask how long treatment might last, how monitoring works, and what signs should trigger a call.
- Attend all follow-ups; consistency helps your team adjust therapy safely.
Educational content only. Not medical advice. Your healthcare team will decide which tests and treatments are appropriate for you.